Nano-immunoassay with improved performance for detection of cancer biomarkers

  • Alexey V. Krasnoslobodtsev
  • , María P. Torres
  • , Sukhwinder Kaur
  • , Ivan V. Vlassiouk
  • , Robert J. Lipert
  • , Maneesh Jain
  • , Surinder K. Batra
  • , Yuri L. Lyubchenko

    Research output: Contribution to journalArticlepeer-review

    49 Scopus citations

    Abstract

    Nano-immunoassay utilizing surface-enhanced Raman scattering (SERS) effect is a promising analytical technique for early detection of cancer. In its current standing the assay is capable of discriminating samples of healthy individuals from samples of pancreatic cancer patients. Further improvements in sensitivity and reproducibility will extend practical applications of the SERS-based detection platforms to wider range of problems. In this report, we discuss several strategies designed to improve performance of the SERS-based detection system. We demonstrate that reproducibility of the platform is enhanced by using atomically smooth mica surface as a template for preparation of capture surface in SERS sandwich immunoassay. Furthermore, assay's stability and sensitivity can be further improved by using either polymer or graphene monolayer as a thin protective layer applied on top of the assay addresses. The protective layer renders signal to be more stable against photo-induced damage and carbonaceous contamination. From the Clinical Editor: This study discusses strategies to improve the performance of nano-immunoassays utilizing surface-enhanced Raman scattering (SERS) effect , an analytical technique with high sensitivity that holds a great promise for early cancer biomarker detection.

    Original languageEnglish
    Pages (from-to)167-173
    Number of pages7
    JournalNanomedicine: Nanotechnology, Biology, and Medicine
    Volume11
    Issue number1
    DOIs
    StatePublished - Jan 1 2015

    Funding

    Financial support: The work was supported by grants EPS-1004094 ( NSF ) and 5R01GM096039-04 ( National Institutes of Health ) to Y.L.L.; National Institutes of Health ( EDRN UO1 CA111294 , P50 CA 127297 ) to S.K.B. and Nebraska Research Initiative (NRI) grant to M.J., Y.L.L. and A.V.K.

    Keywords

    • AFM
    • Cancer biomarkers
    • Nano-immunoassay
    • Nanodiagnostics
    • Pancreatic cancer
    • Surface-enhanced Raman scattering (SERS)

    Fingerprint

    Dive into the research topics of 'Nano-immunoassay with improved performance for detection of cancer biomarkers'. Together they form a unique fingerprint.

    Cite this